|
Capital Stock Transactions - Additional Information (Detail) (USD $)
|
1 Months Ended | 12 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | 1 Months Ended | 9 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Jan. 23, 2013
|
Jan. 31, 2013
|
Dec. 31, 2012
|
Sep. 30, 2012
|
Jun. 30, 2012
|
Mar. 31, 2013
|
Mar. 31, 2012
|
Aug. 15, 2012
|
Mar. 31, 2013
September 2012
|
Mar. 31, 2013
December 2012
|
Jun. 07, 2012
Holder issued waiver
|
Dec. 28, 2013
Scenario, Forecast
|
Mar. 31, 2013
Restricted Stock
|
Mar. 31, 2012
Restricted Stock
|
Mar. 31, 2013
Restricted Stock
Minimum
|
Mar. 31, 2013
Restricted Stock
Maximum
|
Dec. 28, 2011
Performance and Market Condition RSAs
|
Mar. 31, 2013
Performance and Market Condition RSAs
|
Mar. 31, 2013
Performance and Market Condition RSAs
Group One
|
Mar. 31, 2013
Performance and Market Condition RSAs
Group Two
|
Sep. 30, 2012
Time and Performance Condition RSAs
|
Jan. 03, 2012
Time and Performance Condition RSAs
|
Dec. 31, 2012
Time and Performance Condition RSAs
|
Mar. 31, 2013
Time and Performance Condition RSAs
|
Apr. 30, 2013
Time and Performance Condition RSAs
Subsequent Event
|
Mar. 31, 2013
Time and Performance Condition RSAs
Minimum
|
Mar. 31, 2013
Time and Performance Condition RSAs
Maximum
|
Mar. 31, 2013
Time Condition RSAs
|
Mar. 31, 2012
Time Condition RSAs
|
Mar. 31, 2013
Time Condition RSAs
Minimum
|
Mar. 31, 2013
Time Condition RSAs
Maximum
|
Mar. 31, 2012
Warrant
|
Mar. 31, 2013
Warrant
|
May 31, 2012
Warrant
|
Dec. 31, 2012
Vendor three
|
Mar. 31, 2013
Vendor three
|
May 31, 2012
Director
Transaction one
|
Mar. 31, 2013
Director
Transaction one
|
Jun. 30, 2012
Vendor One
|
Mar. 31, 2013
Vendor One
|
Jul. 31, 2012
Vendor Two
|
Mar. 31, 2013
Vendor Two
|
Sep. 30, 2012
Employment Agreement
|
Mar. 31, 2013
Employment Agreement
|
Dec. 31, 2012
Vendor four
|
Mar. 31, 2013
Vendor four
|
Jan. 31, 2013
Other Vendors
|
Mar. 31, 2013
Other Vendors
|
Mar. 31, 2013
Vendor five
|
Mar. 31, 2013
Vendor five
|
May 31, 2012
Advisory Board Member
|
Mar. 31, 2013
Advisory Board Member
|
|
| Class of Stock [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Series A convertible preferred stock, shares authorized | 2,000,000 | 2,000,000 | 2,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Series A Convertible Preferred Stock, issued | 100,000 | 100,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Series A Convertible Preferred Stock, outstanding | 100,000 | 100,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Series A Convertible Preferred Stock, par value | $ 0.0001 | $ 0.0001 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Liquidation preference, per shares | $ 10 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Series A Convertible Preferred Stock, liquidation preference | The Series A holders are entitled to (1) vote on an equal per share basis as common stock, (2) dividends paid to the common stock holders on an as if-converted basis and (3) a liquidation preference equal to the greater of $50 per share of Series A (subject to adjustment) or such amount that would have been paid to the common stock holders on an as if-converted basis. | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Common stock shares issued, shares | 48,114 | 30,000 | 30,000 | 5,031 | 92,857 | 59,542 | 10,000 | 30,000 | ||||||||||||||||||||||||||||||||||||||||||||
| Vesting period | 1 year | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity Issuance, Per Share Amount | $ 3.50 | $ 3.50 | $ 3.50 | $ 5.00 | $ 4.00 | $ 4.00 | $ 5.00 | |||||||||||||||||||||||||||||||||||||||||||||
| Common stock shares issued | $ 113,000 | $ 113,000 | $ 135,000 | $ 133,000 | $ 20,000 | $ 20,000 | $ 348,000 | $ 348,000 | $ 216,000 | $ 216,000 | $ 47,000 | $ 47,000 | $ 150,000 | $ 135,000 | ||||||||||||||||||||||||||||||||||||||
| Common stock issued, share | 157,143 | 285,714 | 285,714 | 86,667 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Stock Option And Warrant vested in period | 433,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Stock Option And Warrant Expense | 391,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Warrants issued | 39,286 | 71,428 | 71,428 | 23,214 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Warrants, exercise price per share | 3.50 | 3.50 | 3.50 | 3.50 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Term of Warrant | 5 years | 5 years | 5 years | 5 years | ||||||||||||||||||||||||||||||||||||||||||||||||
| Fair value of warrant issued | 134,000 | 251,000 | 255,000 | 82,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Common stock shares issued in connection with acquisition, shares | 133,333 | 187,500 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Business acquisition share price | $ 4.00 | $ 4.20 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Common stock shares issued in connection with acquisition | 788,000 | 787,000 | 533,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Vesting of shares issued to employee, shares | 300,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Vesting of shares issued to employee | 69,000 | 1,200,000 | 267,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Loss on fair value of warrants | (1,255,000) | 21,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair market value of shares | 473,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Forfeited | 26,998 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Shares issued upon exercise of warrant | 73,002 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair value of warrant derivative liabilities | 452,000 | 0 | 473,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Warrant to Purchase | 2,500,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Common stock, shares authorized | 200,000,000 | 200,000,000 | 200,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Period for which share is restricted from individual selling from the date of vesting | 3 months | 2 years | 1 year | 1 year | 2 years | 3 months | 2 years | |||||||||||||||||||||||||||||||||||||||||||||
| Number of shares issued | 365,000 | 5,065,000 | 3,170 | 445 | 365 | 1,450 | ||||||||||||||||||||||||||||||||||||||||||||||
| Gross proceed | 5,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Stock Trading Period | 30 days | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Average daily trading price for Common Stock | 100,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Enterprise value | 200,000,000 | 100,000,000 | 200,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Voting Power | 50.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Economic interest | 50.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Share based compensation arrangement by share based payment award vesting description | (i) one third vested upon the completion our most recent equity financing; (ii) one third shall vest if on any date during the term or within 12 months following the term, our total enterprise value equals or exceeds $100,000; and (iii) one third shall vest immediately if on any date during the term or within 12 months following the term our total enterprise value equals or exceeds $200,000; | The vesting is as follows: (i) one third (1/3) shall vest immediately upon the completion of one or more debt or equity financings during the period ending two (2) years from the date hereof (the “Measurement Period”) in favor of the Company of gross proceeds of at least $5 million; (ii) one third (1/3) shall vest immediately if on any date during the Measurement Period the Company’s total enterprise value (computed by multiplying the number of outstanding shares of Common Stock on a fully diluted (taking into account only those stock options that are in-the-money on such date), as-converted basis by the average daily trading price for Common Stock for the thirty (30) trading day period immediately preceding the date of determination) equals or exceeds $100 million; and (iii) one third (1/3) shall vest immediately if on any date during the Measurement Period the Company’s total enterprise value (calculated as set forth in clause (ii) above) equals or exceeds $200 million; provided, however, that all unvested shares of restricted common stock shall vest immediately upon the sale of all or substantially all of the assets of the Company, upon the merger or reorganization of the Company following which the equity holders of the Company immediately prior to the consummation of such merger or reorganization collectively own less than 50% of the voting power of the resulting entity, or upon the sale of equity securities of the Company representing 50% or more of the voting power of the Company or 50% or more of the economic interest in the Company in a single transaction or in a series of related transactions. | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Value of financing agreement entered into by the Company | 7,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Number of restricted shares, vested | 903,000 | 1,992,000 | 1,057 | 85 | 175 | 50 | 85 | 1,488 | ||||||||||||||||||||||||||||||||||||||||||||
| Value of vested RSAs | 3,223,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Share price per share | $ 3.35 | $ 3.05 | $ 3.25 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Fair value per share | $ 1.40 | $ 1.03 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Volatility | 100.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Restricted stock discount | 36.10% | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Risk free interest rate | 0.10% | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Dividend yield | 0.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Compensation expense | $ 4,831,000 | $ 955,000 | $ 1,130,000 | $ 5,219,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Number of restricted shares, unvested | 2,575,000 | 3,113,000 | 270 | 50 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Probability of meeting the performance criteria | 0.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Number of restricted shares, issued | 1,815 | |||||||||||||||||||||||||||||||||||||||||||||||||||